Stockreport

Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer [Yahoo! Finance]

Kairos Pharma, Ltd.  (KAPA) 
PDF LOS ANGELES, December 17, 2025 BUSINESS WIRE Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeut [Read more]